A carregar...

Nanomedicines in the treatment of acromegaly: focus on pegvisomant

This article examines the role of pegvisomant in the treatment of acromegaly. This syndrome, caused by excessive growth hormone (GH) secretion by a pituitary adenoma, is associated with a doubled mortality rate and poor quality of life. Pituitary microsurgery has long been the first choice of treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Roelfsema, Ferdinand, Biermasz, Nienke R, Pereira, Alberto M, Romijn, Johannes M
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676637/
https://ncbi.nlm.nih.gov/pubmed/17722273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!